Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
SCIENTIFIC WORKS
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
PDF) The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
PDF) The Hamster Model of Sequential Oral Carcinogenesis: An Update
Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6
PDF) Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma
PDF) FGFR-2 and -3 Play an Important Role in Initial Stages of Oral Oncogenesis
SCIENTIFIC WORKS
SCIENTIFIC WORKS
PDF) The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
PDF) The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect? | Anticancer Research
Panos ANTSAKLIS | Obstetrics & Gynecology | Research profile
PDF) The Hamster Model of Sequential Oral Carcinogenesis: An Update
Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6
A Next-Generation Sequencing approach for the study of hereditary tumors
Cancers | Free Full-Text | Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6
PDF) Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma
SCIENTIFIC WORKS
PDF) Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
The Hamster Model of Sequential Oral Carcinogenesis: An Update | In Vivo
